Does EMAPALUMAB Cause Off label use? 67 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 67 reports of Off label use have been filed in association with EMAPALUMAB (GAMIFANT). This represents 38.7% of all adverse event reports for EMAPALUMAB.
67
Reports of Off label use with EMAPALUMAB
38.7%
of all EMAPALUMAB reports
22
Deaths
45
Hospitalizations
How Dangerous Is Off label use From EMAPALUMAB?
Of the 67 reports, 22 (32.8%) resulted in death, 45 (67.2%) required hospitalization, and 14 (20.9%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMAPALUMAB. However, 67 reports have been filed with the FAERS database.
What Other Side Effects Does EMAPALUMAB Cause?
Condition aggravated (37)
Drug ineffective (37)
Haemophagocytic lymphohistiocytosis (33)
Multiple organ dysfunction syndrome (22)
Staphylococcal bacteraemia (17)
Adrenal insufficiency (14)
Drug reaction with eosinophilia and systemic symptoms (14)
Respiratory failure (14)
Pyrexia (12)
Disseminated mucormycosis (11)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which EMAPALUMAB Alternatives Have Lower Off label use Risk?
EMAPALUMAB vs EMAPALUMAB-LZSG
EMAPALUMAB vs EMEND
EMAPALUMAB vs EMICIZUMAB
EMAPALUMAB vs EMICIZUMAB-KXWH
EMAPALUMAB vs EMPAGLIFLOZIN